
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $598.6M | $569.5M | $624.8M | $647.5M | $703.2M | |
Revenue Growth (YoY) | -9.55% | -4.85% | 9.7% | 3.63% | 8.61% | |
Cost of Revenues | $131.6M | $141.2M | $162.6M | $195.2M | $227.1M | |
Gross Profit | $467M | $428.3M | $462.2M | $452.3M | $476.1M | |
Gross Profit Margin | 78.02% | 75.21% | 73.97% | 69.85% | 67.71% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $32.8M | $34.7M | $39.6M | $47.5M | $50.1M | |
Other Inc / (Exp) | -$16.1M | -$223.5M | -$205.7M | -$93M | -$13.5M | |
Operating Expenses | $211.3M | $217.6M | $227.4M | $230.6M | $219.7M | |
Operating Income | $255.7M | $210.7M | $234.8M | $221.7M | $256.5M | |
Net Interest Expenses | $100.4M | $98.6M | $105.5M | $113M | $115.3M | |
EBT. Incl. Unusual Items | $139.1M | -$111.4M | -$76.4M | $15.8M | $127.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $710K | $1.8M | $1.2M | $2M | $1M | |
Net Income to Company | $138.4M | -$113.3M | -$77.6M | $13.8M | $126.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $138.4M | -$113.3M | -$77.6M | $13.8M | $126.7M | |
Basic EPS (Cont. Ops) | $0.67 | -$0.52 | -$0.34 | $0.06 | $0.54 | |
Diluted EPS (Cont. Ops) | $0.67 | -$0.52 | -$0.34 | $0.06 | $0.54 | |
Weighted Average Basic Share | $206.2M | $219.1M | $230.9M | $231.2M | $233.5M | |
Weighted Average Diluted Share | $207.3M | $219.1M | $230.9M | $232.8M | $236M | |
EBITDA | $416.3M | $166.2M | $216.9M | $311.8M | $412.6M | |
EBIT | $239.6M | -$12.8M | $29.1M | $128.7M | $243M | |
Revenue (Reported) | $598.6M | $569.5M | $624.8M | $647.5M | $703.2M | |
Operating Income (Reported) | $255.7M | $210.7M | $234.8M | $221.7M | $256.5M | |
Operating Income (Adjusted) | $239.6M | -$12.8M | $29.1M | $128.7M | $243M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $152.4M | $163.1M | $161.3M | $166.7M | $183.5M | |
Revenue Growth (YoY) | 2.02% | 7.05% | -1.09% | 3.36% | 10.07% | |
Cost of Revenues | $34.1M | $38.1M | $47.8M | $54M | $59.9M | |
Gross Profit | $118.3M | $125M | $113.5M | $112.8M | $123.6M | |
Gross Profit Margin | 77.63% | 76.63% | 70.37% | 67.62% | 67.35% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.9M | $10.4M | $10.5M | $11.9M | $12.7M | |
Other Inc / (Exp) | -$4.4M | -$3.5M | -$30.4M | -$2.8M | $429K | |
Operating Expenses | $55.3M | $55.7M | $63.3M | $54.8M | $56.2M | |
Operating Income | $62.9M | $69.3M | $50.2M | $58M | $67.4M | |
Net Interest Expenses | $24.4M | $25M | $28.5M | $28.4M | $27.1M | |
EBT. Incl. Unusual Items | $34.1M | $40.9M | -$8.8M | $26.7M | $40.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $700K | $284K | $728K | $453K | $413K | |
Net Income to Company | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Basic EPS (Cont. Ops) | $0.16 | $0.18 | -$0.04 | $0.11 | $0.17 | |
Diluted EPS (Cont. Ops) | $0.16 | $0.18 | -$0.04 | $0.11 | $0.17 | |
Weighted Average Basic Share | $211.5M | $230.9M | $231.2M | $231.5M | $237.9M | |
Weighted Average Diluted Share | $212.6M | $231.6M | $231.2M | $233.4M | $240.3M | |
EBITDA | $103M | $111.1M | $72.6M | $98M | $111.3M | |
EBIT | $58.6M | $65.9M | $19.8M | $55.1M | $67.8M | |
Revenue (Reported) | $152.4M | $163.1M | $161.3M | $166.7M | $183.5M | |
Operating Income (Reported) | $62.9M | $69.3M | $50.2M | $58M | $67.4M | |
Operating Income (Adjusted) | $58.6M | $65.9M | $19.8M | $55.1M | $67.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $601.6M | $580.3M | $623M | $652.9M | $720M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $133.5M | $145.2M | $172.3M | $201.4M | $233M | |
Gross Profit | $468.1M | $435M | $450.7M | $451.5M | $487M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $32.9M | $36.1M | $39.7M | $48.9M | $50.9M | |
Other Inc / (Exp) | -$18.9M | -$220.6M | -$232.7M | -$65.4M | -$10.2M | |
Operating Expenses | $213.1M | $219.9M | $235M | $222M | $221.1M | |
Operating Income | $255M | $215.1M | $215.7M | $229.5M | $265.9M | |
Net Interest Expenses | $99.2M | $99.2M | $109M | $112.8M | $114M | |
EBT. Incl. Unusual Items | $137M | -$104.7M | -$126M | $51.2M | $141.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $368K | $1.4M | $1.7M | $1.7M | $965K | |
Net Income to Company | $136.6M | -$106.1M | -$127.7M | $49.5M | $140.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $136.6M | -$106.1M | -$127.7M | $49.5M | $140.8M | |
Basic EPS (Cont. Ops) | $0.66 | -$0.49 | -$0.56 | $0.20 | $0.60 | |
Diluted EPS (Cont. Ops) | $0.66 | -$0.49 | -$0.56 | $0.20 | $0.59 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $413.1M | $174.4M | $178.4M | $337.2M | $425.9M | |
EBIT | $236.2M | -$5.5M | -$17M | $164.1M | $255.7M | |
Revenue (Reported) | $601.6M | $580.3M | $623M | $652.9M | $720M | |
Operating Income (Reported) | $255M | $215.1M | $215.7M | $229.5M | $265.9M | |
Operating Income (Adjusted) | $236.2M | -$5.5M | -$17M | $164.1M | $255.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $152.4M | $163.1M | $161.3M | $166.7M | $183.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $34.1M | $38.1M | $47.8M | $54M | $59.9M | |
Gross Profit | $118.3M | $125M | $113.5M | $112.8M | $123.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $8.9M | $10.4M | $10.5M | $11.9M | $12.7M | |
Other Inc / (Exp) | -$4.4M | -$3.5M | -$30.4M | -$2.8M | $429K | |
Operating Expenses | $55.3M | $55.7M | $63.3M | $54.8M | $56.2M | |
Operating Income | $62.9M | $69.3M | $50.2M | $58M | $67.4M | |
Net Interest Expenses | $24.4M | $25M | $28.5M | $28.4M | $27.1M | |
EBT. Incl. Unusual Items | $34.1M | $40.9M | -$8.8M | $26.7M | $40.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $700K | $284K | $728K | $453K | $413K | |
Net Income to Company | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Basic EPS (Cont. Ops) | $0.16 | $0.18 | -$0.04 | $0.11 | $0.17 | |
Diluted EPS (Cont. Ops) | $0.16 | $0.18 | -$0.04 | $0.11 | $0.17 | |
Weighted Average Basic Share | $211.5M | $230.9M | $231.2M | $231.5M | $237.9M | |
Weighted Average Diluted Share | $212.6M | $231.6M | $231.2M | $233.4M | $240.3M | |
EBITDA | $103M | $111.1M | $72.6M | $98M | $111.3M | |
EBIT | $58.6M | $65.9M | $19.8M | $55.1M | $67.8M | |
Revenue (Reported) | $152.4M | $163.1M | $161.3M | $166.7M | $183.5M | |
Operating Income (Reported) | $62.9M | $69.3M | $50.2M | $58M | $67.4M | |
Operating Income (Adjusted) | $58.6M | $65.9M | $19.8M | $55.1M | $67.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $59.1M | $112M | $49.3M | $41.3M | $60.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $160.6M | $138.1M | $147.9M | $133.8M | $131.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $285.1M | $254M | $201.8M | $180.5M | $198.1M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $332.7M | $153.7M | $186M | $194.7M | $182.9M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $82.8M | $54.1M | $40.1M | $30.9M | $27.5M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $6B | $6B | $5.7B | $5.4B | $5.3B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $146.3M | $143M | $339.2M | $231.4M | $224.5M | |
Long-Term Debt | $2.4B | $2.4B | $2.3B | $2.3B | $2.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.6B | $2.6B | $2.7B | $2.6B | $2.6B | |
Common Stock | $2.1M | $2.3M | $2.3M | $2.3M | $2.4M | |
Other Common Equity Adj | -$39.9M | -$10M | $19.1M | $23.7M | $20.9M | |
Common Equity | $3.4B | $3.4B | $3.1B | $2.8B | $2.7B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.4B | $3.4B | $3.1B | $2.8B | $2.7B | |
Total Liabilities and Equity | $6B | $6B | $5.7B | $5.4B | $5.3B | |
Cash and Short Terms | $59.1M | $112M | $49.3M | $41.3M | $60.5M | |
Total Debt | $2.4B | $2.4B | $2.5B | $2.4B | $2.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $24.9M | $24.8M | $33.5M | $59.9M | $22.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $188.5M | $155.8M | $132.7M | $148.4M | $126.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $274.3M | $185M | $171.4M | $214.3M | $155.3M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $328.6M | $150.1M | $192.1M | $191.8M | $182.8M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $6B | $5.9B | $5.6B | $5.4B | $5.2B | |
Accounts Payable | $123.5M | $118.3M | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $123.5M | $118.3M | $222.6M | $258.9M | $112.1M | |
Long-Term Debt | $2.3B | $2.4B | $2.3B | $2.3B | $2.4B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $2.5B | $2.5B | $2.6B | $2.6B | $2.5B | |
Common Stock | $2.2M | $2.3M | $2.3M | $2.3M | $2.4M | |
Other Common Equity Adj | -$6.4M | $1.7M | $17.4M | $31.2M | $15.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3.5B | $3.4B | $3B | $2.8B | $2.7B | |
Total Liabilities and Equity | $6B | $5.9B | $5.6B | $5.4B | $5.2B | |
Cash and Short Terms | $24.9M | $24.8M | $33.5M | $59.9M | $22.7M | |
Total Debt | $2.3B | $2.4B | $2.4B | $2.5B | $2.4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $138.4M | -$113.3M | -$77.6M | $13.8M | $126.7M | |
Depreciation & Amoritzation | $176.7M | $179M | $187.8M | $183.1M | $169.6M | |
Stock-Based Compensation | $7.9M | $7.9M | $7.5M | $7.9M | $9M | |
Change in Accounts Receivable | -$6.4M | $8.2M | -$6.4M | -$11.1M | -$15.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $354.9M | $356.4M | $315.7M | $300.6M | $310.5M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -$142.9M | -$5.2M | -$1.3M | |
Cash From Investing | -$136.5M | -$336.2M | -$216.2M | $103.1M | -$109M | |
Dividends Paid (Ex Special Dividend) | -$278.3M | -$262.9M | -$277.2M | -$277.4M | -$280.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $791.5M | $204M | $12.2M | $14.6M | |
Long-Term Debt Repaid | -$3.1M | -$767.7M | -$81.3M | -$106.3M | -$2M | |
Repurchase of Common Stock | -- | -- | -$4.8M | -$2.7M | -- | |
Other Financing Activities | -$830K | -$39.5M | -$2.5M | -$36M | -$94K | |
Cash From Financing | -$202.1M | $30.1M | -$161.7M | -$410.3M | -$181.6M | |
Beginning Cash (CF) | $49.1M | $65.5M | $115.9M | $53.9M | $46.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $16.3M | $50.3M | -$62.2M | -$6.6M | $20M | |
Ending Cash (CF) | $65.5M | $115.9M | $53.9M | $46.7M | $66.3M | |
Levered Free Cash Flow | $354.9M | $356.4M | $315.7M | $300.6M | $310.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Depreciation & Amoritzation | $44.4M | $45.3M | $52.8M | $42.9M | $43.5M | |
Stock-Based Compensation | $2.3M | $2.5M | $2.2M | $2.5M | $2.7M | |
Change in Accounts Receivable | -$2.9M | -$5.5M | -$2.8M | -$6.3M | -$2.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $68.5M | $63.1M | $68.3M | $52.8M | $80.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | $729K | -$4.8M | -$188K | -$1M | |
Cash From Investing | -$35.4M | -$37.2M | $113.2M | -$13.2M | -$16.4M | |
Dividends Paid (Ex Special Dividend) | -$63.2M | -$69.3M | -$69.4M | -$69.4M | -$71.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $16.6M | $12.2M | $52.4M | -- | |
Long-Term Debt Repaid | -$93.7M | -$56.1M | -$490K | -$503K | -$24.4M | |
Repurchase of Common Stock | -- | -- | -$1.8M | -$2.6M | -$5.4M | |
Other Financing Activities | -- | -$6K | -$18.1M | -$80K | -$80K | |
Cash From Financing | -$69.3M | -$112.5M | -$196.1M | -$20.2M | -$101.2M | |
Beginning Cash (CF) | $65.5M | $115.9M | $53.9M | $46.7M | $66.3M | |
Foreign Exchange Rate Adjustment | $65K | $40K | -$641K | -$131K | -$19K | |
Additions / Reductions | -$36.1M | -$86.6M | -$14.6M | $19.3M | -$37.4M | |
Ending Cash (CF) | $29.5M | $29.3M | $38.7M | $65.9M | $28.9M | |
Levered Free Cash Flow | $68.5M | $63.1M | $68.3M | $52.8M | $80.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $136.6M | -$106.1M | -$127.7M | $49.5M | $140.8M | |
Depreciation & Amoritzation | $176.9M | $179.9M | $195.4M | $173.2M | $170.2M | |
Stock-Based Compensation | $7.8M | $8.1M | $7.2M | $8.2M | $9.2M | |
Change in Accounts Receivable | -$2.4M | $5.6M | -$3.8M | -$14.6M | -$12M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $348.6M | $351M | $320.9M | $285.1M | $338M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | $729K | -$148.4M | -$626K | -$2.1M | |
Cash From Investing | -$102M | -$338.1M | -$65.8M | -$23.3M | -$112.2M | |
Dividends Paid (Ex Special Dividend) | -$249.1M | -$269M | -$277.2M | -$277.5M | -$282.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -$101M | $808.1M | $199.7M | $52.4M | -- | |
Long-Term Debt Repaid | -$95.9M | -$730M | -$25.7M | -$106.3M | -$25.9M | |
Repurchase of Common Stock | -- | -- | -$6.7M | -- | -- | |
Other Financing Activities | -- | -$39.5M | -$20.6M | -$18M | -$94K | |
Cash From Financing | -$280.3M | -$13.1M | -$245.3M | -$234.5M | -$262.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$33.8M | -$212K | $9.8M | $27.4M | -$36.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $348.6M | $351M | $320.9M | $285.1M | $338M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $33.4M | $40.6M | -$9.5M | $26.3M | $40.3M | |
Depreciation & Amoritzation | $44.4M | $45.3M | $52.8M | $42.9M | $43.5M | |
Stock-Based Compensation | $2.3M | $2.5M | $2.2M | $2.5M | $2.7M | |
Change in Accounts Receivable | -$2.9M | -$5.5M | -$2.8M | -$6.3M | -$2.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $68.5M | $63.1M | $68.3M | $52.8M | $80.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | $729K | -$4.8M | -$188K | -$1M | |
Cash From Investing | -$35.4M | -$37.2M | $113.2M | -$13.2M | -$16.4M | |
Dividends Paid (Ex Special Dividend) | -$63.2M | -$69.3M | -$69.4M | -$69.4M | -$71.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $16.6M | $12.2M | $52.4M | -- | |
Long-Term Debt Repaid | -$93.7M | -$56.1M | -$490K | -$503K | -$24.4M | |
Repurchase of Common Stock | -- | -- | -$1.8M | -$2.6M | -$5.4M | |
Other Financing Activities | -- | -$6K | -$18.1M | -$80K | -$80K | |
Cash From Financing | -$69.3M | -$112.5M | -$196.1M | -$20.2M | -$101.2M | |
Beginning Cash (CF) | $65.5M | $115.9M | $53.9M | $46.7M | $66.3M | |
Foreign Exchange Rate Adjustment | $65K | $40K | -$641K | -$131K | -$19K | |
Additions / Reductions | -$36.1M | -$86.6M | -$14.6M | $19.3M | -$37.4M | |
Ending Cash (CF) | $29.5M | $29.3M | $38.7M | $65.9M | $28.9M | |
Levered Free Cash Flow | $68.5M | $63.1M | $68.3M | $52.8M | $80.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.